W. Kruse et al., PATTERNS OF DRUG COMPLIANCE WITH MEDICATIONS TO BE TAKEN ONCE AND TWICE-DAILY ASSESSED BY CONTINUOUS ELECTRONIC MONITORING IN PRIMARY-CARE, International journal of clinical pharmacology and therapeutics, 32(9), 1994, pp. 452-457
Adherence to drug treatment is difficult to assess in routine medical
practice. Therefore, electronic compliance monitoring and a new comput
er software program, the PC-RDP (Reader, Display, Printer) system was
used. It allows instant evaluation of a patient's dosing record, at th
e patient's return to the practice. Compliance was measured in 24 pati
ents on antihypertensive treatment, either continuous (n = 8) or newly
prescribed treatment (n = 16) in primary care, for a total period of
5144 patient days. Fifteen patients received compliance feedback by th
eir physician, 9 did not receive feedback. The drugs prescribed were t
riamterene plus hydrochlorothiazide, as a single dose, once daily (QD)
, and nifedipine twice daily (BID). The mean percentages of prescribed
doses taken were 89% (QD) and 88% (BID). Partial compliance was 10 ti
mes more often (1243 days) than overcompliance (114 days), and days wi
thout dosing were observed twice as frequently with the QD than the BI
D regimen. Omissions of doses occurred more often on weekends than any
other day of the week. With the BID regimen, evening doses were omitt
ed twice as often as morning doses. When treatment was initiated, comp
liance was consistently high until the end of the study period, wherea
s in patients on continuous treatment, it decreased over time. Both co
mpliance feedback (n = 11/16) and the beginning of treatment may be im
portant factors to explain the difference in compliance behavior. An i
mplementation of compliance monitoring into practical patient care see
ms to be feasible and promising.